UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Re: Routine first‐trimester combined screening for pre‐eclampsia: pregnancy‐associated plasma protein‐A or placental growth factor?

Ultrasound in obstetrics & gynecology, 2022-03, Vol.59 (3), p.404-404

Cuckle, H.

2022

Volltextzugriff (PDF)

Local validation and calibration of pre‐eclampsia screening algorithms

Ultrasound in obstetrics & gynecology, 2019-06, Vol.53 (6), p.724-728

Cuckle, H.

2019

Volltextzugriff (PDF)

Rethinking second‐trimester Down‐syndrome screening in the cell‐free DNA era

Ultrasound in obstetrics & gynecology, 2019-10, Vol.54 (4), p.431-436

Cuckle, H.

2019

Volltextzugriff (PDF)

cfDNA screening performance: accounting for and reducing test failures

Ultrasound in obstetrics & gynecology, 2017-06, Vol.49 (6), p.689-692

Cuckle, H.

2017

Volltextzugriff (PDF)

Non‐invasive prenatal testing for aneuploidy: current status and future prospects

Ultrasound in obstetrics & gynecology, 2013-07, Vol.42 (1), p.15-33

2013

Volltextzugriff (PDF)

Extending the provision of cell‐free DNA screening for trisomy 21

BJOG : an international journal of obstetrics and gynaecology, 2021-01, Vol.128 (2), p.447-447

Cuckle, HS

2021

Volltextzugriff (PDF)

Re: Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis. I. Maya, S. Yacobson, S. Kahana, J. Yeshaya, T. Tenne, I. Agmon‐Fishman, L. Cohen‐Vig, M. Shohat, L. Basel‐Vanagaite and R. Sharony. Ultrasound Obstet Gynecol 2017; 50: 332–335

Ultrasound in obstetrics & gynecology, 2017-09, Vol.50 (3), p.293-294

Cuckle, H.

2017

Volltextzugriff (PDF)

Rational and irrational ratios

Ultrasound in obstetrics & gynecology, 2016-09, Vol.48 (3), p.275-278

Cuckle, H.

2016

Volltextzugriff (PDF)

First trimester pre‐eclampsia screening: why delay implementation?

BJOG : an international journal of obstetrics and gynaecology, 2018-03, Vol.125 (4), p.450-450

Cuckle, HS

2018

Volltextzugriff (PDF)

Screening for Pre-eclampsia–Lessons from Aneuploidy Screening

Placenta (Eastbourne), 2011-02, Vol.32, p.S42-S48

Cuckle, H.S

2011

Volltextzugriff (PDF)

Re: Repeat measurements of nuchal translucency at 11–14 weeks of gestation: when do we need them? L. J. Salomon, R. Porcher, D. Socolov, H. Lamrani and Y. Ville. Ultrasound Obstet Gynecol 2013; 42: 629–633

Ultrasound in obstetrics & gynecology, 2013-12, Vol.42 (6), p.613-613

Cuckle, H.

2013

Volltextzugriff (PDF)

First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia

BJOG : an international journal of obstetrics and gynaecology, 2010-10, Vol.117 (11), p.1384-1389

2010

Volltextzugriff (PDF)

A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound

Ultrasound in obstetrics & gynecology, 2006-01, Vol.27 (1), p.13-17

2006

Volltextzugriff (PDF)

Quality assessment of first‐trimester screening for preterm pre‐eclampsia

Ultrasound in obstetrics & gynecology, 2022-12, Vol.60 (6), p.746-750

2022

Volltextzugriff (PDF)

Early pregnancy prediction of spontaneous preterm birth before 32 completed weeks of pregnancy using plasma RNA: transcriptome discovery and initial validation of an RNA panel of markers

BJOG : an international journal of obstetrics and gynaecology, 2021-10, Vol.128 (11), p.1870-1880

2021

Volltextzugriff (PDF)

Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review

Health technology assessment (Winchester, England), 2004-08, Vol.8 (33), p.iii-iii

2004

Volltextzugriff (PDF)

Re: Routinefirst‐trimestercombinedscreening for pre‐eclampsia: pregnancy‐associated plasma protein‐A or placental growth factor?

Ultrasound in obstetrics & gynecology, 2022-03, Vol.59 (3), p.404-404

Cuckle, H

2022

Volltextzugriff (PDF)

Change in prevalence of preterm birth in Israel following publication of national guidelines recommending routine sonographic cervical‐length measurement at 19–25 weeks' gestation

Ultrasound in obstetrics & gynecology, 2023-05, Vol.61 (5), p.610-616

2023

Volltextzugriff (PDF)

What will be the role of first‐trimester ultrasound if cell‐free DNA screening for aneuploidy becomes routine?

Ultrasound in obstetrics & gynecology, 2014-12, Vol.44 (6), p.621-630

2014

Volltextzugriff (PDF)

Non‐invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly

Ultrasound in obstetrics & gynecology, 2012-02, Vol.39 (2), p.127-130

2012

Volltextzugriff (PDF)

Role of second‐trimester ultrasound in screening for Down syndrome

Ultrasound in obstetrics & gynecology, 2013-03, Vol.41 (3), p.241-244

2013

Volltextzugriff (PDF)

First‐ and second‐trimester maternal serum markers of pre‐eclampsia in twin pregnancy

Ultrasound in obstetrics & gynecology, 2016-05, Vol.47 (5), p.560-564

2016

Volltextzugriff (PDF)

First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA

Prenatal diagnosis, 2013-11, Vol.33 (11), p.1044-1049

2013

Volltextzugriff (PDF)

Reply

Ultrasound in obstetrics & gynecology, 2017-01, Vol.49 (1), p.158

Cuckle, H

2017

Volltextzugriff (PDF)

Reply

Ultrasound in obstetrics & gynecology, 2017-01, Vol.49 (1), p.158-158

Cuckle, H.

2017

Volltextzugriff (PDF)

1 – 25 von 405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(338)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Re: Routine first‐trimester combined screening for pre‐eclampsia: pregnancy‐associated plasma protein‐A or placental growth factor?

Local validation and calibration of pre‐eclampsia screening algorithms

Rethinking second‐trimester Down‐syndrome screening in the cell‐free DNA era

cfDNA screening performance: accounting for and reducing test failures

Non‐invasive prenatal testing for aneuploidy: current status and future prospects

Extending the provision of cell‐free DNA screening for trisomy 21

Re: Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis. I. Maya, S. Yacobson, S. Kahana, J. Yeshaya, T. Tenne, I. Agmon‐Fishman, L. Cohen‐Vig, M. Shohat, L. Basel‐Vanagaite and R. Sharony. Ultrasound Obstet Gynecol 2017; 50: 332–335

Rational and irrational ratios

First trimester pre‐eclampsia screening: why delay implementation?

Screening for Pre-eclampsia–Lessons from Aneuploidy Screening

Re: Repeat measurements of nuchal translucency at 11–14 weeks of gestation: when do we need them? L. J. Salomon, R. Porcher, D. Socolov, H. Lamrani and Y. Ville. Ultrasound Obstet Gynecol 2013; 42: 629–633

First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia

A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound

Quality assessment of first‐trimester screening for preterm pre‐eclampsia

Early pregnancy prediction of spontaneous preterm birth before 32 completed weeks of pregnancy using plasma RNA: transcriptome discovery and initial validation of an RNA panel of markers

Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review

Re: Routinefirst‐trimestercombinedscreening for pre‐eclampsia: pregnancy‐associated plasma protein‐A or placental growth factor?

Change in prevalence of preterm birth in Israel following publication of national guidelines recommending routine sonographic cervical‐length measurement at 19–25 weeks' gestation

What will be the role of first‐trimester ultrasound if cell‐free DNA screening for aneuploidy becomes routine?

Non‐invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly

Role of second‐trimester ultrasound in screening for Down syndrome

First‐ and second‐trimester maternal serum markers of pre‐eclampsia in twin pregnancy

First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA

Reply

Reply

Suchergebnisse filtern